NCT00139893View on ClinicalTrials.gov

A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis

NACompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2005

Conditions
Diabetic Gastroparesis
Interventions
DRUG

Reglan ODT

Trial Locations (1)

Unknown

Schwarz, Milwaukee

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00139893 - A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis | Biotech Hunter | Biotech Hunter